Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 822

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 822
---
 share and per share data)

A summary of restricted stock unit activity related to employees and non-employee members of the Company’s Board of Directors as of and for the year ended December 31, 2023 is as follows:

| ​                                                                           
 ​                                                                           
 ​                                                                           
 ​                                                                           | ​ 
 ​ 
 ​ |         ​ 
         ​ 
 Number of 
     Units | ​ 
 ​ 
 ​ | ​               
 Weighted        
 Average Grant   
 Date Fair Value |      ​ |
|:----------------------------------------------------------------------------|:--|----------:|:--|:----------------|-------:|
| Outstanding, December 31, 2022                                              |   |    31,043 | ​ | $               | 158.40 |
| Awarded                                                                     |   |    50,098 | ​ |                 |  93.72 |
| Vested and released                                                         |   |   -16,939 | ​ |                 | 149.52 |
| Forfeited                                                                   |   |   -17,008 | ​ |                 | 107.52 |
| Outstanding, December 31, 2023                                              |   |    47,194 | ​ | $               | 111.24 |
| Restricted stock units exercisable (vested and deferred), December 31, 2023 |   |         — | ​ | ​               |      ​ |

Stock Options

A summary of the Company’s stock option activity related to employees, non-employee members of the Board of Directors and non-employee consultants for the 2019 Plan and the 2014 Plan as of and for the year ended December 31, 2023 is as follows:

| ​                                                                              
 ​                                                                              
 ​                                                                              
 ​                                                                              | ​ 
 ​ 
 ​ |         ​ 
         ​ 
 Number of 
    Shares | ​ 
 ​ 
 ​ | ​                
 Weighted         
 Average Exercise 
 Price            |      ​ | ​ 
 ​ 
 ​ | ​         
 Aggregate 
 Intrinsic 
 Value     | ​ |
|:-------------------------------------------------------------------------------|:--|----------:|:--|:-----------------|-------:|:--|:----------|:--|
| Outstanding, December 31, 2022                                                 |   |   640,787 | ​ | $                | 172.20 |   | ​         |   |
| Granted                                                                        |   |   167,056 | ​ |                  |  97.80 |   | ​         |   |
| Exercised                                                                      |